Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment

Published:2013-10-21 Issue:11 Volume:7 Page:9571-9584
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Deng Zhou J.¹²,Morton Stephen W.¹²,Ben-Akiva Elana¹²,Dreaden Erik C.¹²,Shopsowitz Kevin E.¹²,Hammond Paula T.¹²

Affiliation:

1. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Rm 76-553, Cambridge, Massachusetts 02139, United States,

2. Department of Chemical Engineering, Massachusetts Institute of Technology, Rm 76-553, Cambridge, Massachusetts 02139, United States

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn4047925

Reference50 articles.

1. Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

2. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

3. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks

4. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

5. Knocking down barriers: advances in siRNA delivery

Cited by 465 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date);Discover Nano;2024-09-03

2. Polypeptide-based multilayer nanoarchitectures: Controlled assembly on planar and colloidal substrates for biomedical applications;Advances in Colloid and Interface Science;2024-09

3. Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer;Critical Reviews in Oncology/Hematology;2024-09

4. Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach;Biomacromolecules;2024-08-26

5. Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy;Bioengineering;2024-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3